Literature DB >> 6294010

How does increased cardiac output increase shunt in pulmonary edema?

P H Breen, P T Schumacker, G Hedenstierna, J Ali, P D Wagner, L D Wood.   

Abstract

In pulmonary edema, the relationship between cardiac output (QT) and shunt (QS/QT) may be due to a diffusion barrier for O2 transfer (incomplete alveolar-capillary equilibration) or to redistribution of increased pulmonary blood flow toward edematous units. We compared transfer of O2 and multiple inert gases in the left (LLL) and right (RLL) lower lobes and in the whole lungs of eight dogs having oleic acid edema in LLL. When mean QT was increased from 3.0 to 5.5 l X min-1 during O2 ventilation, relative perfusion of LLL did not increase but QS/QT increased because LLL shunt increased from 56 to 78%. We conclude that increased pulmonary blood flow is not redistributed toward edematous regions, but we cannot exclude such redistribution within LLL and other slightly edematous lobes. In LLL, inert gas shunt and O2 shunt were not systematically different during O2 ventilation, and lobar venous PO2 measured during air ventilation was not different from that predicted by inert gas transfer. We conclude that diffusion limitation for O2 does not contribute to QS/QT or to the increase in QS/QT when QT increases. Conceivably, increased QT increased QS/QT by increasing edema or hematocrit in edematous regions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294010     DOI: 10.1152/jappl.1982.53.5.1273

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  10 in total

Review 1.  Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies.

Authors:  Shi-ping Luh; Chi-huei Chiang
Journal:  J Zhejiang Univ Sci B       Date:  2007-01       Impact factor: 3.066

2.  Effects of pulmonary edema on regional blood volume and red blood cell transit time. Comparison of high pressure and oleic acid-induced edema.

Authors:  J Y Tsang; J S Montaner; J C Hogg
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  Pulmonary edema, shunt and blood flow distribution. Problems, progress and perspectives.

Authors:  P T Schumacker
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 4.  Contribution of multiple inert gas elimination technique to pulmonary medicine. 5. Ventilation-perfusion relationships in acute respiratory failure.

Authors:  C Mélot
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

5.  How do changes in exhaled CO₂ measure changes in cardiac output? A numerical analysis model.

Authors:  Peter H Breen
Journal:  J Clin Monit Comput       Date:  2010-11-17       Impact factor: 2.502

6.  Dependence of shunt on cardiac output in unilobar oleic acid edema. Distribution of ventilation and perfusion.

Authors:  F Fredén; I Cigarini; F Mannting; A Hagberg; F Lemaire; G Hedenstierna
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 7.  Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?

Authors:  John Y C Tsang; James C Hogg
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 8.  Limitations of oxygen transport to the cell.

Authors:  P D Wagner
Journal:  Intensive Care Med       Date:  1995-05       Impact factor: 17.440

9.  Ventilation with biphasic positive airway pressure in experimental lung injury. Influence of transpulmonary pressure on gas exchange and haemodynamics.

Authors:  Dietrich Henzler; Rolf Dembinski; Ralf Bensberg; Nadine Hochhausen; Rolf Rossaint; Ralf Kuhlen
Journal:  Intensive Care Med       Date:  2004-02-24       Impact factor: 17.440

10.  Hypoxia and exercise increase the transpulmonary passage of 99mTc-labeled albumin particles in humans.

Authors:  Melissa L Bates; Emily T Farrell; Alyssa Drezdon; Joseph E Jacobson; Scott B Perlman; Marlowe W Eldridge
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.